肝癌血供研究进展

Research progress in blood of liver cancer

对于不能手术切除的肝脏恶性肿瘤,经血管途径行介入治疗可获得可靠疗效。所以准确的描述肿瘤血供对肝癌的介入治疗就显得尤为重要。近年来研究表明,肝癌血供较为复杂,存在肝动脉、肝外侧支、门静脉供血及肝动脉门静脉双重供血等情况。随着介入治疗次数的增加,肝癌血供亦发生变化。肝癌血供研究直接影响对其介入治疗方式的选择和疗效。

There are reliability therapeutic effects in transvascular interventional therapy on unresectable liver cancer. It is important to exactly describe the blood supply of liver cancer in interventional therapy. In the past few years, studies indicate that the presence of blood supply of liver cancer involving hepatic artery, extrahepatic collateral arteries, portal vein, and both hepatic artery and portal vein. The blood supply of liver cancer can be changed after multiple interventional therapy. These studies directly influence the alternative of modality in interventional therapy and therapeutic effect.